Wolverine Trading
GALT icon

Wolverine Trading’s Galectin Therapeutics GALT Stock Holding History

Wolverine Trading’s Portfolio GALT Stock Details GALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16,700
Closed -$25.4K – 5043
2025
Q1 		$25.4K Sell
16,700
-19,100
-53% -$26.8K ﹤0.01% 4536
2024
Q4 		$39.4K Buy
+35,800
New +$85.8K ﹤0.01% 5025
2022
Q3 		– Sell
-18,300
Closed -$23K – 4840
2022
Q2 		$23K Sell
18,300
-2,000
-10% -$2.88K ﹤0.01% 4211
2022
Q1 		$35K Buy
20,300
+8,100
+66% +$15.7K ﹤0.01% 5163
2021
Q4 		$26K Buy
+12,200
New +$34.8K ﹤0.01% 5473
2021
Q2 		– Sell
-24,800
Closed -$50K – 6246
2021
Q1 		$50K Buy
+24,800
New +$55.6K ﹤0.01% 5643
2020
Q1 		– Sell
-16,400
Closed -$46K – 4833
2019
Q4 		$46K Sell
16,400
-300
-2% -$1.04K ﹤0.01% 4475
2019
Q3 		$61K Sell
16,700
-2,700
-14% -$9.76K ﹤0.01% 4012
2019
Q2 		$81K Sell
19,400
-16,000
-45% -$69.3K ﹤0.01% 4082
2019
Q1 		$181K Sell
35,400
-5,200
-13% -$25K ﹤0.01% 3895
2018
Q4 		$153K Buy
40,600
+10,700
+36% +$51.1K ﹤0.01% 3821
2018
Q3 		$180K Buy
29,900
+7,600
+34% +$41.8K ﹤0.01% 4304
2018
Q2 		$106K Hold
22,300
– – ﹤0.01% 4704
2018
Q1 		$106K Buy
+22,300
New +$104K ﹤0.01% 4704
2017
Q4 		– Sell
-14,200
Closed -$30K – 5102
2017
Q3 		$30K Buy
+14,200
New +$28.1K ﹤0.01% 4285
2016
Q4 		– Sell
-31,900
Closed -$39K – 4658
2016
Q3 		$39K Buy
+31,900
New +$56.7K ﹤0.01% 4434

Other funds holding GALT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Wolverine Trading's GALT Position: Q3 2022 in Review

Wolverine Trading sold out of Galectin Therapeutics (GALT) in Q3 2022, closing a stake of 12,310 shares — an estimated $23K sold.

Wolverine Trading first reported a position in GALT in Q3 2016 and held it in 10 quarters. The position peaked at $103K in Q3 2018. 59 funds tracked by Wall St. Rank hold GALT as of Q3 2022.

  • Wolverine Trading reported no remaining Galectin Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Wolverine Trading sold 12,310 Galectin Therapeutics shares in Q3 2022, an estimated $23K.
  • Wolverine Trading first reported a position in Galectin Therapeutics in Q3 2016 and held it in 10 quarters.
  • Wolverine Trading's Galectin Therapeutics position peaked at $103K in Q3 2018.
  • 59 funds tracked by Wall St. Rank held Galectin Therapeutics as of Q3 2022.

Based on Wolverine Trading's 13F filing for Q3 2022, filed 14 Nov 2022.